Duvortuxizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Duvortuxizumab, covering 2025-02-03 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma [Phase 1]